Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies
Jérémy Dufloo, View ORCID ProfileLudivine Grzelak, Isabelle Staropoli, View ORCID ProfileYoann Madec, View ORCID ProfileLaura Tondeur, François Anna, View ORCID ProfileStéphane Pelleau, View ORCID ProfileAurélie Wiedemann, View ORCID ProfileCyril Planchais, View ORCID ProfileJulian Buchrieser, Rémy Robinot, View ORCID ProfileMarie-Noëlle Ungeheuer, View ORCID ProfileHugo Mouquet, View ORCID ProfilePierre Charneau, Michael White, View ORCID ProfileYves Lévy, Bruno Hoen, Arnaud Fontanet, View ORCID ProfileOlivier Schwartz, View ORCID ProfileTimothée Bruel
doi: https://doi.org/10.1101/2020.11.12.20230508
Jérémy Dufloo
1Virus & Immunity Unit, Department of Virology, Institut Pasteur, CNRS UMR3569, Paris, France
2Sorbonne Paris Cité, Université de Paris, Paris, France
Ludivine Grzelak
1Virus & Immunity Unit, Department of Virology, Institut Pasteur, CNRS UMR3569, Paris, France
2Sorbonne Paris Cité, Université de Paris, Paris, France
Isabelle Staropoli
1Virus & Immunity Unit, Department of Virology, Institut Pasteur, CNRS UMR3569, Paris, France
Yoann Madec
3Emerging Diseases Epidemiology Unit, Department of Global Health, Institut Pasteur, Paris, France
Laura Tondeur
3Emerging Diseases Epidemiology Unit, Department of Global Health, Institut Pasteur, Paris, France
François Anna
4Pasteur-TheraVectys joined unit, Institut Pasteur, Paris, France
Stéphane Pelleau
5Malaria: Parasites and Hosts Unit, Department of Parasites and Insect Vectors, Institut Pasteur, Paris, France
Aurélie Wiedemann
6Vaccine Research Institute, Faculté de Médecine, INSERM U955, Université Paris-Est Créteil, Créteil, France
Cyril Planchais
7Laboratory of Humoral Immunology, Department of Immunology, Institut Pasteur, INSERM U1222, Paris, France
Julian Buchrieser
1Virus & Immunity Unit, Department of Virology, Institut Pasteur, CNRS UMR3569, Paris, France
Rémy Robinot
1Virus & Immunity Unit, Department of Virology, Institut Pasteur, CNRS UMR3569, Paris, France
Marie-Noëlle Ungeheuer
8Investigation Clinique et Accès aux Ressources Biologiques (ICAReB), Center for Translational Research, Institut Pasteur, Paris, France
Hugo Mouquet
7Laboratory of Humoral Immunology, Department of Immunology, Institut Pasteur, INSERM U1222, Paris, France
Pierre Charneau
4Pasteur-TheraVectys joined unit, Institut Pasteur, Paris, France
9Molecular Virology and Vaccinology Unit, Department of Virology, Institut Pasteur, Paris, France
Michael White
5Malaria: Parasites and Hosts Unit, Department of Parasites and Insect Vectors, Institut Pasteur, Paris, France
Yves Lévy
6Vaccine Research Institute, Faculté de Médecine, INSERM U955, Université Paris-Est Créteil, Créteil, France
Bruno Hoen
10Direction de la recherche médicale, Institut Pasteur, Paris, France
Arnaud Fontanet
3Emerging Diseases Epidemiology Unit, Department of Global Health, Institut Pasteur, Paris, France
Olivier Schwartz
1Virus & Immunity Unit, Department of Virology, Institut Pasteur, CNRS UMR3569, Paris, France
6Vaccine Research Institute, Faculté de Médecine, INSERM U955, Université Paris-Est Créteil, Créteil, France
Timothée Bruel
1Virus & Immunity Unit, Department of Virology, Institut Pasteur, CNRS UMR3569, Paris, France
6Vaccine Research Institute, Faculté de Médecine, INSERM U955, Université Paris-Est Créteil, Créteil, France
Posted November 15, 2020.
Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies
Jérémy Dufloo, Ludivine Grzelak, Isabelle Staropoli, Yoann Madec, Laura Tondeur, François Anna, Stéphane Pelleau, Aurélie Wiedemann, Cyril Planchais, Julian Buchrieser, Rémy Robinot, Marie-Noëlle Ungeheuer, Hugo Mouquet, Pierre Charneau, Michael White, Yves Lévy, Bruno Hoen, Arnaud Fontanet, Olivier Schwartz, Timothée Bruel
medRxiv 2020.11.12.20230508; doi: https://doi.org/10.1101/2020.11.12.20230508
Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies
Jérémy Dufloo, Ludivine Grzelak, Isabelle Staropoli, Yoann Madec, Laura Tondeur, François Anna, Stéphane Pelleau, Aurélie Wiedemann, Cyril Planchais, Julian Buchrieser, Rémy Robinot, Marie-Noëlle Ungeheuer, Hugo Mouquet, Pierre Charneau, Michael White, Yves Lévy, Bruno Hoen, Arnaud Fontanet, Olivier Schwartz, Timothée Bruel
medRxiv 2020.11.12.20230508; doi: https://doi.org/10.1101/2020.11.12.20230508
Subject Area
Subject Areas
- Addiction Medicine (354)
- Allergy and Immunology (678)
- Anesthesia (182)
- Cardiovascular Medicine (2678)
- Dermatology (227)
- Emergency Medicine (404)
- Epidemiology (12310)
- Forensic Medicine (10)
- Gastroenterology (769)
- Genetic and Genomic Medicine (4158)
- Geriatric Medicine (390)
- Health Economics (685)
- Health Informatics (2694)
- Health Policy (1010)
- Hematology (365)
- HIV/AIDS (861)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (444)
- Neurology (3931)
- Nursing (212)
- Nutrition (584)
- Oncology (2071)
- Ophthalmology (596)
- Orthopedics (243)
- Otolaryngology (307)
- Pain Medicine (253)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1131)
- Primary Care Research (461)
- Public and Global Health (6578)
- Radiology and Imaging (1420)
- Respiratory Medicine (876)
- Rheumatology (414)
- Sports Medicine (345)
- Surgery (455)
- Toxicology (54)
- Transplantation (189)
- Urology (169)